ANTITHROMBOTIC AGENTS STIMULATE the SYNTHESIS and MODIFY the SULFATION PATTERN of A HEPARAN-SULFATE PROTEOGLYCAN FROM ENDOTHELIAL-CELLS

ANTITHROMBOTIC AGENTS STIMULATE the SYNTHESIS and MODIFY the SULFATION PATTERN of A HEPARAN-SULFATE PROTEOGLYCAN FROM ENDOTHELIAL-CELLS

Autor Pinhal, MAS Google Scholar
Walenga, J. M. Google Scholar
Jeske, W. Google Scholar
Hoppensteadt, D. Google Scholar
Dietrich, C. P. Google Scholar
Fareed, J. Google Scholar
Nader, H. B. Google Scholar
Instituição LOYOLA UNIV
Universidade Federal de São Paulo (UNIFESP)
Resumo Low molecular weight heparins, namely CY 216 and CY 222 (Sanofi/Choay); OP 622 and OP 386 (Opocrin); PK 10169 (Pharmuka); an oligosaccharide prepared from heparin by heparitinase 11 digestion; chemically sulfated glycosaminoglycans and polysaccharide namely Suleparoid (Syntex), Aprosulate (Luitpold-Werk); chemically modified glycosaminoglycans GAGPS and MPS (Luitpold-Werk) as well as unmodified heparin stimulate two to three fold the synthesis of a heparan sulfate with antithrombotic activity secreted by endothelial cells in culture. the stimulation is concentration dependent and specific for the endothelial cell. the [S-35]-heparan sulfate synthesized in the presence of heparin and/or the tested antithrombotic agents has shown a high degree of sulfation of the iduronic acid residues as revealed by the analyses of the disaccharide products formed from the heparan sulfate by the action of bacterial heparitinases. the features of the above compounds in common with heparin are their polymeric nature and a high charge density, as well as their pharmacological activities as potent antithrombotic agents ''in vivo''. These combined observations reinforce the proposition that the antithrombotic activity of heparin, low molecular weight heparins and the chemically modified polysaccharides could be related to the increased production of this peculiar heparan sulfate by endothelial cells.
Palavra-chave ANTITHROMBOTICS, ENDOTHELIAL CELL HEPARAN SULFATE
HEPARAN SULFATE SYNTHESIS VS ANTITHROMBOTICS
HEPARAN SULFATE, ANTITHROMBOTICS
HEPARIN and ENDOTHELIAL CELL
Idioma Inglês
Data de publicação 1994-04-15
Publicado em Thrombosis Research. Oxford: Pergamon-Elsevier B.V., v. 74, n. 2, p. 143-153, 1994.
ISSN 0049-3848 (Sherpa/Romeo, fator de impacto)
Publicador Elsevier B.V.
Extensão 143-153
Fonte http://dx.doi.org/10.1016/0049-3848(94)90007-8
Direito de acesso Acesso restrito
Tipo Artigo
Web of Science WOS:A1994NB78700007
Endereço permanente http://repositorio.unifesp.br/handle/11600/25403

Exibir registro completo




Arquivo

Arquivo Tamanho Formato Visualização

Não existem arquivos associados a este item.

Este item está nas seguintes coleções

Buscar


Navegar

Minha conta